PMA device
AcrySof IQ Vivity Extended Vision
Alcon Laboratories, Inc. · Extended Depth Of Focus Intraocular Lens (POE, Class III) · First FDA decision Feb 26, 2020, newest Feb 26, 2020Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
16
Naming "AcrySof IQ Vivity"
MAUDE reports
1,535
Brand "AcrySof IQ Vivity", since 2015
PubMed studies
80
Mentioning "AcrySof IQ Vivity"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AcrySof IQ Vivity Extended Vision
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- AcrySof IQ Vivity Extended Vision, Toric Extended Vision, Extended Vision UV Absorbing, and Toric Extended Vision UV APMA supplement
P930014-S126 · Decided Feb 26, 2020 · 201 days after receipt · Panel Track
Device type: Extended depth of focus intraocular lens (POE) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "AcrySof IQ Vivity", any status and sponsor, newest update first.
Benha UniversityAcademic, hospital or other
NCT07457216 · 30 participants · Start Jan 3, 2025 · Primary completion Jan 30, 2025
Device: AcrySof IQ Vivity EDOF Intraocular Lens · For: Extended Depth-of-Focus Intraocular Lens; Cataract; Visual Acuity
Sites: Banhā, Egypt
- Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage KeratoconusCompleted
Azienda Ospedaliera Universitaria Integrata VeronaAcademic, hospital or other
NCT07338708 · 10 participants · Start Sep 17, 2024 · Primary completion May 13, 2025
Device: Extended Depth of Focus Intraocular Lens Implantation · For: Cataract; Keratoconic Subjects
Sites: Verona, Italy
Alcon ResearchNot on our public-company list
NCT06541795 · 0 participants · Start Jun 2025 · Primary completion Dec 2026
Device: AcrySof IQ Vivity Extended Vision IOL · For: Aphakia; Presbyopia; Residual Refractive Cylinder
Sites: Fort Worth, Texas
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AcrySof IQ Vivity", and for the whole product code for context.
This brand
1,535 reports: 540 malfunction, 995 injury, 0 death
Whole product code POE
6,053 reports: 1,242 malfunction, 4,811 injury, 0 death
Newest reports for this brand
Alcon Research, LLC - Huntington
1119421-2026-02129 · Received Oct 23, 2026 · Event dated Sep 28, 2026
Device type: Extended Depth Of Focus Intraocular Lens (POE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- AcrySof IQ Vivity Extended Vision IOLMalfunction
Alcon Research, LLC - Huntington
1119421-2026-02079 · Received Oct 16, 2026
Device type: Extended Depth Of Focus Intraocular Lens (POE)
Device problem as coded: Failure to Deliver
Patient problem as coded: Insufficient Information
- AcrySof IQ Vivity Extended Vision IOLMalfunction
Alcon Research, LLC - Huntington
1119421-2026-02018 · Received Oct 7, 2026 · Event dated May 29, 2026
Device type: Extended Depth Of Focus Intraocular Lens (POE)
Device problem as coded: Scratched Material
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- AcrySof Intraocular LensTerminated
Z-0431-2007 · Started Dec 14, 2006 · Posted by FDA Feb 15, 2007
Reason given: Intraocular lenses exposed to extreme temperatures while in storage.
Cause as FDA categorized it: Other · Device type: Lens, Multifocal Intraocular (MFK)
Published research
The most relevant PubMed records for "AcrySof IQ Vivity"[tiab]. The summary above synthesizes these.
- Functional outcomes and quality of life after AcrySof IQ Vivity intraocular lens implantation in a real-world study.
Giannuzzi F, Carlà MM, Margollicci F, et al. · Sci Rep · 2024
- Extended depth-of-focus (EDOF) AcrySof® IQ Vivity® intraocular lens implant: a real-life experience.
Arrigo A, Gambaro G, Fasce F, et al. · Graefes Arch Clin Exp Ophthalmol · 2021
- A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia.
Bala C, Athanasiov P, Holland J, et al. · Clin Ophthalmol · 2022
- Visual performance and patient satisfaction with AcrySof® IQ Vivity® IOL: Experience from a tertiary care center in central India.
Bhasin P, Sarkar D, Bhasin P, et al. · Indian J Ophthalmol · 2024Observational Study
- Clinical outcomes of bilateral implantation of a new non-diffractive extended-vision intraocular lens (AcrySof® IQ vivity).
Costa C, Cortinhal T, Figueiredo I, et al. · Eur J Ophthalmol · 2026
- Evaluation of Visual Acuity, Postoperative Refractive Error, and Optical Aberrations in Patients With Previous Corneal Surgery and AcrySof IQ Vivity Intraocular Lens Implantation.
Srur M, Villagran E, Segovia C, et al. · J Ophthalmol · 2025
- Assessment of vivity with French clinical data related to the toric model study.
Koch E, Morel M, Duchateau N · Sci Rep · 2025Research Support, Non-U.S. Gov't
- Comparison of U.S. FDA premarket approval studies between two non-diffractive extended depth of focus lenses (AcrySof IQ Vivity versus TECNIS PureSee).
Adamji Z, Pawlowski H, Molleti S, et al. · Med Hypothesis Discov Innov Ophthalmol · 2026
- Profile of a new extended range-of-vision IOL: a laboratory study.
Tognetto D, Giglio R, De Giacinto C, et al. · Graefes Arch Clin Exp Ophthalmol · 2022
- Clinical Outcomes after Bilateral Implantation of a Wavefront-Shaping Extended Depth of Focus (EDOF) IOL with Mini-Monovision.
Won YK, Choi SH, Chung TY, et al. · J Clin Med · 2024
- Through-Focus Response of Extended Depth of Focus Intraocular Lenses.
Pieh S, Artmayr C, Pai V, et al. · J Refract Surg · 2022
- Visualization of Ray Propagation through Extended Depth-of-Focus Intraocular Lenses.
Baur ID, Auffarth GU, Yan W, et al. · Diagnostics (Basel) · 2022
Other devices of this type
Also filed under product code POE.
- IC-8 Apthera Intraocular Lens (IOL)Acu Focus, Inc. · PMA 2026
- TECNIS Symfony Extended Range Of Vision Intraocular LensJohnson & Johnson Surgical Vision, Inc. · PMA 2023
- Clareon Vivity Pro Extended Vision IOLsAlcon Laboratories, LLC · PMA 2026
- TECNIS Symfony PLUS Extended Range of Vision Intraocular Lens (IOL)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.